EV/EBITDA
-3.48
+0.17+4.66%
7 min ago
Summary
- As of March 10, 2025, ORIC EV/EBITDA is -3.48, with a rise of +0.17 (+4.66%) during the most recent trading day.
- Over the past year, ORIC EV/EBITDA has increased by +5.57 (+61.55%).
- ORIC EV/EBITDA is now -700.00% below its all-time high of 0.58.
Performance
ORIC EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ORIC EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +4.7% | -4.7% | -4.2% |
1 m1 month | +32.0% | -32.2% | -29.9% |
3 m3 months | - | - | -15.9% |
6 m6 months | +34.1% | -24.8% | -22.4% |
ytdytd | - | - | -4.2% |
1 y1 year | +61.5% | -50.4% | -48.6% |
5 y5 years | - | - | - |
ORIC EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -2.0% | -5.74 | +39.4% | |
3 m | 3-month | -3.41 | -2.0% | -5.74 | +39.4% |
6 m | 6-month | -3.41 | -2.0% | -6.16 | +43.5% |
1 y | 1-year | -3.22 | -8.1% | -9.63 | +63.9% |
3 y | 3-year | 0.58 | -700.0% | -9.63 | +63.9% |
5 y | 5-year | 0.58 | -700.0% | -34.92 | +90.0% |
alltime | all time | 0.58 | -700.0% | -34.92 | +90.0% |
ORIC Pharmaceuticals EV/EBITDA History
Date | Value |
---|---|
2025 | -3.48(-18.5%) |
2023 | -4.27(+82.5%) |
Date | Value |
---|---|
2022 | -2.34(-48.7%) |
2021 | -4.56(-81.0%) |
2020 | -24.04 |
FAQ
- What is ORIC Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals EV/EBITDA year-on-year change?
What is ORIC Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of ORIC is -3.48
What is the all time high EV/EBITDA for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high EV/EBITDA is 0.58
What is ORIC Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, ORIC EV/EBITDA has changed by +5.57 (+61.55%)